نتایج جستجو برای: multidrug resistante mdr

تعداد نتایج: 31348  

Journal: :International journal of oncology 2013
Shi Zhong Ke Xiao Yan Ni Yue Hua Zhang Yi Nan Wang Bin Wu Feng Guang Gao

Multidrug resistance (MDR) formation is an important problem in lung cancer chemotherapy. Our study showed that both camptothecin and cisplatin could not only induce ATM and NF-κB activation but also upregulate expression of the MDR-related genes ABCG2, MRP2 in NCI-H446 cells. Moreover, camptothecin and cisplatin-induced ABCG2 and MRP2 upregulation could be impaired by ATM and NF-κB inhibitors,...

Journal: :The Lancet. Infectious diseases 2012
James A Seddon Peter Godfrey-Faussett Anneke C Hesseling Robert P Gie Nulda Beyers H Simon Schaaf

Children exposed to multidrug-resistant (MDR) Mycobacterium tuberculosis are at risk of developing MDR tuberculosis. Where treatment is available, it is lengthy, expensive, and associated with poor adherence and notable morbidity and mortality. Preventive treatment effectively lowers the risk of disease progression for contacts of individuals with drug-susceptible tuberculosis, but this strateg...

Journal: :Cancer research 2009
Dóra Türk Matthew D Hall Benjamin F Chu Joseph A Ludwig Henry M Fales Michael M Gottesman Gergely Szakács

There is a great need for the development of novel chemotherapeutic agents that overcome the emergence of multidrug resistance (MDR) in cancer. We catalogued the National Cancer Institute's DTP drug repository in search of compounds showing increased toxicity in MDR cells. By comparing the sensitivity of parental cell lines with MDR derivatives, we identified 22 compounds possessing MDR-selecti...

2009
Dóra Türk Matthew D. Hall Benjamin F. Chu Joseph A. Ludwig Henry M. Fales Michael M. Gottesman Gergely Szakács

There is a great need for the development of novel chemotherapeutic agents that overcome the emergence of multidrug resistance (MDR) in cancer. We catalogued the National Cancer Institute's DTP drug repository in search of compounds showing increased toxicity in MDR cells. By comparing the sensitivity of parental cell lines with MDR derivatives, we identified 22 compounds possessing MDR-selecti...

2015
Atieh Sadat Moini Babak Soltani Abbas Taghavi Ardakani Alireza Moravveji Mahzad Erami Mostafa Haji Rezaei Mansoor Namazi

BACKGROUND Escherichia coli and Klebsiella pneumoniae are common human pathogens that cause a wide spectrum of infections. Antimicrobial resistance is a basic obstacle in the management of these infections which has different patterns in various regions. OBJECTIVES In this study, the antibiotic resistance patterns and risk factors for multidrug-resistant (MDR) E. coli and K. pneumoniae were d...

Journal: :Cancer research 2000
M J Newman J C Rodarte K D Benbatoul S J Romano C Zhang S Krane E J Moran R T Uyeda R Dixon E S Guns L D Mayer

OC144-093 is a novel substituted diarylimidazole (Mr 495) generated using the OntoBLOCK system, a solid-phase combinatorial chemistry technology, in combination with high-throughput cell-based screening. OC144-093 reversed multidrug resistance (MDR) to doxorubicin, paclitaxel, and vinblastine in human lymphoma, breast, ovarian, uterine, and colorectal carcinoma cell lines expressing P-glycoprot...

2018
Muyang Yang Lixia Yu Ruiwei Guo Anjie Dong Cunguo Lin Jianhua Zhang

Synergistic combination therapy by integrating chemotherapeutics and chemosensitizers into nanoparticles has demonstrated great potential to reduce side effects, overcome multidrug resistance (MDR), and thus improve therapeutic efficacy. However, with regard to the nanocarriers for multidrug codelivery, it remains a strong challenge to maintain design simplicity, while incorporating the desirab...

2017
Tara C. Bouton Patrick P. J. Phillips Carole D. Mitnick Charles A. Peloquin Kathleen Eisenach Ramonde F. Patientia Leonid Lecca Eduardo Gotuzzo Neel R. Gandhi Donna Butler Andreas H. Diacon Bruno Martel Juan Santillan Kathleen Robergeau Hunt Dante Vargas Florian von Groote-Bidlingmaier Carlos Seas Nancy Dianis Antonio Moreno-Martinez C. Robert Horsburgh

BACKGROUND Current guidelines for treatment of multidrug-resistant tuberculosis (MDR-TB) are largely based on expert opinion and observational data. Fluoroquinolones remain an essential part of MDR-TB treatment, but the optimal dose of fluoroquinolones as part of the regimen has not been defined. METHODS/DESIGN We designed a randomized, blinded, phase II trial in MDR-TB patients comparing acr...

Journal: :The European respiratory journal 2015
Jose A Caminero Anna Scardigli

Multidrug-resistant (MDR) tuberculosis (TB) (resistance to at least isoniazid and rifampicin), with >480000 cases in 2013, 10% of them being affected by extensively drug-resistant (XDR)-TB (MDR-TB with additional resistance to any fluoroquinolone, and to injectable second-line drugs (SLDs) (capreomycin, kanamycin or amikacin)), continues to represent a real threat to TB control [1–4]. In some h...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014
David J Ritchie Alexandria Garavaglia-Wilson

Options for treatment of multidrug-resistant (MDR) Acinetobacter baumannii infections are extremely limited. Minocycline intravenous is active against many MDR strains of Acinetobacter, and Clinical and Laboratory Standards Institute breakpoints exist to guide interpretation of minocycline susceptibility results with Acinetobacter. In addition, minocycline intravenous holds a US Food and Drug A...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید